| |
29-08-2008
CMS, Inc., an Elekta Company, announces first cancer patients treated with Monaco™ radiation treatment planning system
|
|
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application. |
|
Read More ...
|
|
| |
25-07-2008
Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
|
|
The Elekta Family of Companies will showcase their unique line of cancer treatment solutions at the 2008 American Association of Physicists in Medicine (AAPM) annual meeting, demonstrating how the joint forces of Elekta, IMPAC and CMS are delivering cutting-edge radiation therapy planning and delivery solutions that streamline the treatment process to create a better experience for patients, as well as enhance clinician efficiency. |
|
Read More ...
|
|
| |
16-06-2008
Elekta VMAT 510(k) Clearance Welcomed by US Radiation Oncologists
|
|
Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology. This news has been eagerly anticipated by US cancer clinics as it offers both significant benefits to their patients and the opportunity to increase patient volumes. |
|
Read More ...
|
|
| |
26-05-2008
Leksell Gamma Knife® Perfexion™ receives regulatory approval in Japan
|
|
The Japanese Ministry for Health, Labor and Welfare, MHLW, has given approval for Leksell Gamma Knife® Perfexion™, the world-leading clinical solution for non-invasive radiosurgical treatments of tumors, vascular malformations and other brain disorders. Elekta, the international medical technology group and developer of Gamma Knife® surgery, will now be able to deliver and install this advanced technology at new and existing customer sites in Japan. |
|
Read More ...
|
|
| |
21-05-2008
Elekta sees record attendance and record number of submitted abstracts at International Leksell Gamma Knife® Society Meeting in Quebec, Canada
|
|
At the 14th International Leksell Gamma Knife® Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorders convened at the historic Château Frontenac Hotel in Quebec, Canada. During the meeting, 260 oral and poster presentations covered treatment of malignant and benign brain tumors, functional neurosurgery, imaging & biology as well as physics & technology. On Wednesday, May 21, the prestigious Pioneers in Radiosurgery Award was presented to John Flickinger, M.D., Professor of Radiation Oncology and Neurological Surgery at the University of Pittsburgh for his early pioneering work on prediction of complications following Gamma Knife® surgery. |
|
Read More ...
|
|
| |
19-05-2008
Australian Safety Agency orders Elekta Synergy® as gold standard for Calibration and Dosimetry
|
|
Elekta, world-leading provider of radiation therapy and radiosurgery solutions, is pleased to announce that the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has joined other world-class physics standards centers with its order of an Elekta linear accelerator. ARPANSA will accept delivery of an Elekta Synergy® system this summer, and will utilize the Elekta system’s high level of stability for its national physics measurements. |
|
Read More ...
|
|
| |
04-03-2008
Elekta completes the acquisition of CMS
|
|
The international medical technology group Elekta AB (publ) (STO: EKTAb) today announced the completion of its announced acquisition of CMS, Inc. for total cash consideration representing an enterprise value of USD 75 M. |
|
Read More ...
|
|
| |
18-02-2008
Elekta signs agreement to acquire CMS
|
|
Elekta AB (publ) (STO:EKTAb) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it has signed a purchase agreement to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. Closing of the transaction is expected in March. |
|
Read More ...
|
|
| |
10-01-2008
Elekta displays innovative cancer treatment solutions at JASTRO 2007
|
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, demonstrated a very strong presence at the 20th annual meeting of the Japanese Society for Therapeutic Radiology and Oncology (JASTRO). With over 1,800 radiation oncologists and radiation therapists in attendance, JASTRO was held December 13-15, 2007 at the Fukuoka Convention Center. |
|
Read More ...
|
|
| |
08-01-2008
Elekta negotiates to acquire CMS
|
|
Acquisition of leading treatment planning software developer would strengthen Elekta’s offering and accelerate the company’s expansion into high growth oncology informatics |
|
Read More ...
|
|
| |
30-10-2007
Beaumont Hospital, Royal Oak treats its first patients with Elekta Axesse™
|
|
Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse™, the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy. The new robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting. |
|
Read More ...
|
|
| |
29-10-2007
Elekta announces Elekta Infinity – a new System for Faster, more precise Treatment of Cancer Tumors
|
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center. |
|
Read More ...
|
|
| |
27-10-2007
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
|
|
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) and Elekta AB (publ) (Stockholm, Sweden: EKTA.ST), edtoday announced a global particle therapy collaboration program to optimize the seamless integration of proton therapy delivery and information management systems within the radiation oncology environment. Both companies currently showcase their products at the 49th Annual Meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) held in Los Angeles, CA, USA, from October 28 to November 1, 2007. |
|
Read More ...
|
|
| |
18-10-2007
Elekta announces new Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
|
|
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, will feature advances in cancer care at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO) that dramatically reduce treatment times and increase efficiency. The meeting will be held October 28 - November 1 at the Los Angeles Convention Center (Los Angeles, California, USA). Elekta will showcase innovative offerings that optimize productivity and workflow, empowering health care professionals to spend more time on patient care. One important highlight will be the announcement of a new Elekta solution for clinical Volumetric Intensity Modulated Arc Therapy* (VMAT) that more precisely targets tumors and protects surrounding healthy tissue, while drastically reducing radiation therapy treatment times. |
|
Read More ...
|
|
| |
25-09-2007
Two new Italian Cancer Centers select Advanced Radiation Treatment Technology from Elekta
|
|
Elekta has been selected by two progressive Italian hospitals opening up new radiation therapy clinics, to supply advanced and clinically proven cancer treatment systems for intensity modulated and image guided radiation therapy (IMRT & IGRT). The two clinics will play an important role in their respective region to provide first class radiation therapy and to increase cancer treatment
capacity. |
|
Read More ...
|
|
| |
12-09-2007
Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
|
|
Elekta is pleased to announce the development of a comprehensive solution for planning and performing Volumetric Intensity Modulated Arc Therapy (VMAT)*. The complete offering of Elekta VMAT solutions are being featured in the Elekta booth at this year’s European Society of Therapeutic Radiation Oncologists (ESTRO) meeting in Barcelona, September 8-13, 2007. Performing VMAT with Elekta enables helical-like conformality and can help reduce total treatment time even with daily use of Elekta’s proven X-ray Volume Imaging system.
|
|
Read More ...
|
|
| |
10-09-2007
Elekta Launches new Linear Accelerator at 2007 ESTRO to expand Cancer Treatment Availability
|
|
Elekta today unveiled a new member of the Elekta family of linear accelerators at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2007 meeting. At an unveiling ceremony in the Elekta booth, Elekta President & CEO Tomas Puusepp announced the launch of Elekta Compact™, a new addition to Elekta's product line of linear accelerators that offers an easy to implement, more affordable solution for radiation therapy. |
|
Read More ...
|
|
| |
03-09-2007
Elekta demonstrates commitment to stereotactic innovation at EANS
|
|
Leading neurosurgical device developer Elekta will feature the newest advances in neurosurgical diagnostic and treatment devices, along with clinical workflow solutions that make neurosurgery more effective and efficient at the European Association of Neurosurgical Societies (EANS) European Congress September 2-7, 2007. More than 1,000 neurosurgeons and related medical professionals will gather at the Scottish Exhibition & Conference Centre in Glasgow for the event. |
|
Read More ...
|
|
| |
04-05-2007
Elekta to supply leading IGRT solution to Vejle Hospital in Denmark
|
|
Vejle hospital has selected Elekta to supply world leading technology for intensity modulated and image guided radiation therapy and two Elekta Synergy® systems will be installed during 2007 and 2008. Elekta Synergy allows the clinicians to visualize the target at the time of treatment, enabling more aggressive treatment of tumors with increased precision and accuracy while minimizing the risk of damage to surrounding healthy tissue. The order is valued at over SEK 30 M.
|
|
Read More ...
|
|
| |
02-05-2007
Elekta receives order to deliver the first Leksell Gamma Knife® Perfexion™ to India
|
|
Elekta today announced a new order from India for Leksell Gamma Knife® Perfexion™, the world's most advanced system for non-invasive radiosurgery of brain disorders including tumors, brain metastases and functional disorders. The purchase decision is an important step in the effort to improve quality and capacity of treatment of brain diseases for the entire northern part of India. The order also demonstrates that Elekta has earned a strong reputation in one of the most interesting emerging markets in the world as a company with state-of-the-art technology and clinical solutions for treatment of cancer and brain disorders. |
|
Read More ...
|
|
| |
23-03-2007
Elekta Acquires 3D Line Medical Systems
|
|
Elekta, world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced the acquisition of 3D Line Medical Systems S.r.l. Through this acquisition, Elekta adds a highly qualified R&D group specialized in stereotactic radiosurgery and dynamic IMRT treatments as well as a product portfolio of advanced equipment and treatment planning software systems for performing radiation therapy with extreme precision and optimized dose distribution. |
|
Read More ...
|
|
| |
05-01-2007
Elekta to deliver Leksell Gamma Knife® Perfexion™ to UPMC
|
|
One of the U.S. premier providers of Gamma Knife® surgery, The University of Pittsburgh Medical Center-Presbyterian (UPMC) in Pittsburgh, has agreed to purchase the new Leksell Gamma Knife® Perfexion™ , the most advanced system ever for non-invasive radiosurgery of brain disorders. UPMC will be one of the first medical centers in the country to install this new system in the early spring of 2007. |
|
| | |